![Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases](https://www.researchgate.net/publication/350693596/figure/fig2/AS:1019671432159232@1620120022518/Gene-expression-of-ceramide-synthetizing-enzymes-is-defective-in-brain-and-kidney-tissues_Q320.jpg)
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
![Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases](https://www.researchgate.net/publication/350693596/figure/fig1/AS:1019671427956736@1620120021458/Expression-of-S1P-receptors-is-aberrant-in-both-brain-and-kidney-tissues-from-SHRSP-and_Q320.jpg)
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
Neuromed on Twitter: "Domani, 18 dicembre alle ore 10.55, Vittorio Maglione,Responsabile del laboratorio di #Neurogenetica del #Neuromed, sarà ospite nello studio di @RaiUno per un intervento sulla malattia di #Huntington. Neuromed e @
![POZZILLI – Il ricercatore Neuromed, Vittorio Maglione, al congresso della Gordon Rearch Conference per presentare i suoi lavori. – Paese News cronaca politica sport caserta e provincia POZZILLI – Il ricercatore Neuromed, Vittorio Maglione, al congresso della Gordon Rearch Conference per presentare i suoi lavori. – Paese News cronaca politica sport caserta e provincia](https://i0.wp.com/www.paesenews.it/wp-content/uploads/vittorio-maglione.jpg?fit=660%2C330&ssl=1)
POZZILLI – Il ricercatore Neuromed, Vittorio Maglione, al congresso della Gordon Rearch Conference per presentare i suoi lavori. – Paese News cronaca politica sport caserta e provincia
![Pozzilli: Vittorio Maglione , ricercatore del Neuromed invitato alla Gordon Conference. Presenterà i suoi lavori sui glicolipidi e sfingolipidi. - News Della Valle Pozzilli: Vittorio Maglione , ricercatore del Neuromed invitato alla Gordon Conference. Presenterà i suoi lavori sui glicolipidi e sfingolipidi. - News Della Valle](http://www.newsdellavalle.com/wp-content/uploads/2016/03/Vittorio-Maglione-web.jpg)
Pozzilli: Vittorio Maglione , ricercatore del Neuromed invitato alla Gordon Conference. Presenterà i suoi lavori sui glicolipidi e sfingolipidi. - News Della Valle
![Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases](https://www.researchgate.net/profile/Enrica-Calce/publication/348382735/figure/fig2/AS:978733213184005@1610359590810/Apoptosis-in-STHdh-111-111-HD-striatal-derived-cells-pre-cultured-with-serum-free-medium_Q320.jpg)
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
![PDF) The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum–microglia crosstalk preventing disease progression in a mouse model of Huntington's disease PDF) The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum–microglia crosstalk preventing disease progression in a mouse model of Huntington's disease](https://i1.rgstatic.net/publication/343044178_The_longevity-associated_variant_of_BPIFB4_improves_a_CXCR4-mediated_striatum-microglia_crosstalk_preventing_disease_progression_in_a_mouse_model_of_Huntington's_disease/links/5f163609299bf1e548c77f4b/largepreview.png)
PDF) The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum–microglia crosstalk preventing disease progression in a mouse model of Huntington's disease
![Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases](https://www.researchgate.net/publication/354842721/figure/fig2/AS:1071963531386880@1632587430284/Altered-RNA-levels-of-components-of-the-mitochondrial-encoded-ETS-complex-and-ATPsynthase_Q320.jpg)
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
![Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases](https://www.researchgate.net/publication/355163632/figure/fig3/AS:1077682783690755@1633951006458/UCP2-gene-silencing-leads-to-ROS-induced-inhibition-of-autophagy-A-ROS-levels-were_Q320.jpg)
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
![Neuromed, La curcumina potrebbe essere un valido aiuto perle persone colpite dalla malattia di Huntington | Molise Protagonista Neuromed, La curcumina potrebbe essere un valido aiuto perle persone colpite dalla malattia di Huntington | Molise Protagonista](https://moliseprotagonista.it/wp-content/uploads/2019/10/Alba-Di-Pardo.jpg)
Neuromed, La curcumina potrebbe essere un valido aiuto perle persone colpite dalla malattia di Huntington | Molise Protagonista
![Ricerca Neuromed. Individuata una strada innovativa per la Malattia di Huntington - Istituto Neuromed Ricerca Neuromed. Individuata una strada innovativa per la Malattia di Huntington - Istituto Neuromed](https://www.neuromed.it/wp-content/uploads/2018/04/ricerca-5.jpg)
Ricerca Neuromed. Individuata una strada innovativa per la Malattia di Huntington - Istituto Neuromed
![Frontiers | De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease | Neuroscience Frontiers | De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease | Neuroscience](https://www.frontiersin.org/files/MyHome%20Article%20Library/307558/307558_Thumb_400.jpg)
Frontiers | De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease | Neuroscience
![Neurology Conferences 2022 | Neuroscience Conferences | Brain Disorders Conference 2022 | Brain Congress 2022 | Neurology Events 2022 Neurology Conferences 2022 | Neuroscience Conferences | Brain Disorders Conference 2022 | Brain Congress 2022 | Neurology Events 2022](https://neurologycongress.com/uploads/gallery/neurology-conference-2018-rome-italy/vittorio-maglione-irccs-neuromed-italy-3105.jpg)
Neurology Conferences 2022 | Neuroscience Conferences | Brain Disorders Conference 2022 | Brain Congress 2022 | Neurology Events 2022
![Ricerca Neuromed. Individuata una strada innovativa per la Malattia di Huntington - Istituto Neuromed Ricerca Neuromed. Individuata una strada innovativa per la Malattia di Huntington - Istituto Neuromed](https://www.neuromed.it/wp-content/uploads/2018/04/Vittorio-Maglione-e-Alba-Di-Pardo-ok-300x193.jpg)
Ricerca Neuromed. Individuata una strada innovativa per la Malattia di Huntington - Istituto Neuromed
![Neurology Conferences 2022 | Neuroscience Conferences | Brain Disorders Conference 2022 | Brain Congress 2022 | Neurology Events 2022 Neurology Conferences 2022 | Neuroscience Conferences | Brain Disorders Conference 2022 | Brain Congress 2022 | Neurology Events 2022](https://neurologycongress.com/uploads/gallery/neurology-conference-2018-rome-italy/vittorio-maglione-feliciated-by-najib-murr-1381.jpg)
Neurology Conferences 2022 | Neuroscience Conferences | Brain Disorders Conference 2022 | Brain Congress 2022 | Neurology Events 2022
![Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases](https://www.researchgate.net/publication/352486139/figure/fig3/AS:1035688094990348@1623938692430/Myr-treatment-induced-TFEB-nuclear-translocation-and-autophagy-in-the-PD-cell-model_Q320.jpg)
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
![Frontiers | Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders | Neuroscience Frontiers | Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders | Neuroscience](https://www.frontiersin.org/files/Articles/325221/fnins-12-00249-HTML/image_m/fnins-12-00249-g001.jpg)